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Post-menopausal women experience variable biological and psychological changes. The effect of reduced levels of estrogen can effect on 
post-menopausal depression. Estrogen triggers physiological responses by binding to the estrogen receptor (ER). Two subtypes of ER, 
ERa and ERb are now known. We investigated the significance of ERa and ERb polymorphisms and post-menopasal depression in this 
study. Forty three women with post-menopausal depression and 63 post-menopausal women without depression as normal controls 
were recruited. Polymerase chain reaction-restriction fragment length polymorphism method was used to investigate genotypes of ERa 
and ERb polymorphisms. Genotypes of PvuII and XbaI polymorphism of ERa receptor were significantly different in patients with post-
menopausal depression comparing with controls. Genotypes of ERb did not show association with post-menopausal depression. Our study 
showed that ERa receptor polymorphism had an association with depression in post-menopausal women. It suggests that investigation 
of ER genes and their functions might be important for understanding pathophysilogical mechanism of post-menopausal depression.
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INTRODUCTION 
Women are vulnerable to depression especially along with 
menopause.
1 Women who had reproductive cycle event-relat-
ed depression such as premenstrual dysphoric disorder, peri-
menopausal depression and postpartum depression reported 
a stronger family history of mental illness than other depressed 
women.
2 It suggests unique characteristics and perhaps a 
more biologically driven illness for this subgroup of depressed 
women.
2 
Post-menopausal women experience variable biological 
and psychological changes. The effect of reduced levels of es-
trogen can effect on post-menopausal depression in suscep-
tible women.
3,4 Estrogen passes the blood-brain barrier, and 
receptors for them are abundant in brain areas such as limbic 
structure important for the regulation of emotions, cognition 
and behavior.
5-8 The fact that men and women differ with re-
spect to the prevalence of depression may possibly also reflect 
an influence of estrogen on human behavior.
6 
Estrogen triggers physiological responses by binding to a nu-
clear receptor protein, the estrogen receptor (ER). ERs are nu-
clear receptor proteins that have an estrogen binding domain 
and a deoxyribonucleic acid (DNA) binding domain.
9 The ER 
is classified as a class 1 member of the superfamily of nuclear 
hormone receptors.
10 Two subtypes of ER are now known, ERa 
and ERb.
11 The ERa gene is localized on chromosome 6q25.1,
12 
and the ERb gene is localized on chromosome 14q22-24.
13 
Recently, several genetic variants of Era and ERb gene were 
described. 
The association of genetic polymorphisms of ER and psy-
chiatric disorders have been the subject of increasing interest.
14 
However, given the important role of estrogen for brain func-
tion and abrupt change of it in postmenopausal period, there 
are relatively few studies so far have addressed the possible in-
fluence of ER polymorphism with respect to susceptibility to 
depression in postmenopausal women.
15-18 
Therefore, we investigated the significance of ERa and ERb 
polymorphisms and post-menopasal depression in this study. 
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METHODS
Forty three women with post-menopausal depression and 63 
post-menopausal women without depression as normal con-
trols in Korean population were recruited for this study. All of 
them were between 45 and 60 years and were not under psy-
chiatric treatment. Post-menopausal women who have intact 
uterus and more than 1 ovary, no sex steroid hormone use in 
the previous 3 months, absence of pregnancy, and previous 
regular menstrual cycle were enrolled. In addition to menstru-
ation history, serum FSH, LH, and estradiol (E2) were tested 
to confirm postmenopausal period in all the women. Post-
menopausal women with Beck Depression Inventory (BDI) 
scores over 21 (39.17±11.04) were evaluated and included as 
postmenopausal depression group if they were diagnosed as 
major depressive disorder or depressive disorder, NOS by 
DSM-IV criteria by psychiatrist. They were not under psy-
chiatric treatment. All the normal controls were under BDI 
score 21 (8.61±2.25) and they were evaluated by psychiatrist 
to be determined as they did not have any kind of depressive 
disorder. They were also performed by other scales such as 
Hamilton Depression Rating Scale, Montgomery-Asberg De-
pression Rating Scale, and State-Trait Anxiety Inventory. Sub-
jects with neurological disorder, endocrine disorder, and other 
psychiatric disorder were excluded in this study. Written in-
formed consent was obtained from all the subjects. 
Genomic DNA from the peripheral blood was extracted 
using DNA Isolation kit (Bioneer, Daejeon, Korea) following 
the manufacturer’s protocol. ERa genotypes were determined 
with polymerase chain reaction-restriction fragment length 
polymorphism (PCR-RFLP) method reported earlier
14 with 
some modification. After PCR, 1.3-kb fragments were digest-
ed by PvuII and XbaI. The primers for analysis of ERb genes 
were ERb genotypes were determined with a PCR-RFLP me-
thod reported earlier.
18 After PCR, the products of 156 and 
307 bp were digested by RsaI and AluI, respectively. The geno-
typing were performed in duplicate manner and interpreted 
by two blind researchers. 
The characteristics of patients by ER genotypes were exam-
ined by means of a one-way analysis of variance for continu-
ous variables and by chi-square analysis for discrete variables. 
The significance level for all statistical tests was 0.05. The sta-
tistical analyses were performed using Statistical Package for 
the Social Sciences (SPSS) 12.0. for Windows (SPSS Inc., Chicago, 
IL, USA).
RESULTS
There were no differences in age distributions between the 
patient (49.9±6.7 yrs) and control groups (50.0±7.3 yrs). Age was 
not associated with genotypes of ERa and ERb polymorphism. 
The Hardy-Weinberg equilibrium (H-W-E) of genotypes 
of ERa and ERb showed some deviation [controls of PvuII 
(p=0.00094), controls of XbaI (p=0.00008), Patients of XbaI 
(p=0.00038), patients of AluI ( p=0.034)]. Levels of linkage dis-
equilibrium between the polymorphisms of ERa and ERb in 
controls were D’=0.2167 and D’=0.01129. 
Genotypes of PvuII and XbaI polymorphism of ERa recep-
tor were significantly different in patients with post-meno-
pausal depression comparing with controls (χ2=13.204, df=2, 
p=0.001; χ2=35.894, df=2, p=0.000, respectively, Table 1). AluI 
and RsaI genotypes of ERb did not show association with post-
menopausal depression (Table 1). For clinical variables of post-
menopausal depression, no clinical variables were related with 
genotypes of ER polymorphisms. (Data not shown) The pow-
er of a sample to detect the differences between the alleles 
was calculated by considering an alpha value of 0.05, two tailed. 
Using these parameters, the sample was estimated to have a 
power (0.80) to detect a small to small effect size (w=0.12), 
which corresponded to a difference of approximately 13% in 
the two alleles between the two groups.
 
DISCUSSION
The two subtypes of ER (ERa and ERb) differ with respect 
to tissue distribution and coregulator interactions.
19,20 TA re-
peat located upstream from exon 1 of ERa may influence the 
tissue specific expression of the ERa gene.
6 The two common 
polymorphisms such as the PvuII (T/C; rs2234693) in the 5’ 
region of the gene and XbaI (A/C; rs9340799) polymorphisms 
in intron 1 are in strong linkage disequilibrium with this re-
peat. Also, PvuII single nucleotide polymorphism (SNP) pro-
Table 1. Genotypes of estrogen receptor polymorphisms in pa-
tients with post-menopausal depression and normal controls
Patients 
(N=43)
Controls
(N=63)
p value
PvaII, N(%) PP 11 (25.6) 18 (28.6) 0.001*
Pp 26 (60.5) 18 (28.6)
pp 06 (13.9) 27 (42.8)
XbaI, N(%) XX 07 (16.3) 6 ( 9.5) 0.000†
Xx 34 (79.1) 18 (28.6)
xx 2 (4.6) 39 (61.9)
AluI, N(%) AA 22 (51.2) 39 (61.9) 0.345
Aa 21 (48.8) 23 (36.5)
aa 0 (0.0) 1 (1.6)
RsaI RR 19 (44.2) 35 (55.6) 0.442
Rr 20 (46.5) 25 (39.7)
rr 4 (9.3) 3 ( 4.7)
*χ2=13.204, df=2, †χ2=35.894, df=2226  Psychiatry Investig 2010;7:224-227
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duces a binding site for a specific transcription factor that 
may affect gene expression.
21 The functional polymorphism of 
ERb was not identified yet, and there are two common SNPs 
such as AluI at position 1730 (G/A; rs4986938) in the 3’ un-
translated region and RsaI silent mutation at position 1082 
(G/A; rs1256049)
22 in exon 5. 
In this study, ERa receptor polymorphisms were strongly 
associated with depression in post-menopausal women. Con-
sidering PvuII and XbaI position of ERa might influence ex-
pression of ERa gene as mentioned above, these results showed 
the importance of functions of ERa polymorphisms in post-
menopausal depression. Otherwise, ERb polymorphism was 
not associated with post-menopausal depression. The two 
polymorphisms examined in this study have not functional 
expression. Further research of ERb should be evaluated in 
post-menopausal depression along with identification of func-
tional polymorphisms. 
To our knowledge, this is the first case-control study of ER 
polymorphisms and post-menopausal depression. The influ-
ence of the ER polymorphism on physical and emotional symp-
toms of post-menopausal women has been insufficiently studied. 
A few previous studies were performed to examine the re-
lationship of ER receptor polymorphisms and postmenopausal 
depression. Malacara et al.
17 reported that ERa polymorphisms 
(PvuII and XbaI) was not associated with emotional symp-
toms in post-menopausal women. In a cohort study, Tiemeier 
et al.
15 also examined the same ERa polymorphisms and found 
no association with depressive symptoms in women over 55 
years. Instead, they found an association of an ERa with anxiety 
symptoms unlike our results. Kravitz et al.
18 analyzed 4 SNPs 
of ERa and ERb in pre- and perimenopausal depression and 
found no association with depressive symptoms and those 
SNPs, although their SNPs were different with our study ex-
cept PvuII of ERa. Majority of the subjects in previous study 
were Caucasians and they did not include normal control sam-
ples. Ethic and socio-cultural and environmental factors are 
involved in the appearance or symptoms of post-menopausal 
depression.
23 
Considering relatively small sample size of our study, which 
may affect deviation of H-W-E and different genotype distri-
bution of ERa polymorphisms in Korean population,
24 further 
studies with larger samples and different ethnic populations 
are recommended to elucidate the function of ER polymor-
phisms and depression in post-menopausal period. Also, giv-
en that a single polymorphism in a single gene could not ex-
ert any major impact on the activity of the sex steroids and on 
aspects of the phenotype that are under the influence of these 
hormones,
6 diverse genetic studies with genes involving es-
trogen function is needed to elucidate pathophisiogic mech-
anism of postmenopausal depression. 
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